Brazil and Russia reached a deal to broaden cooperation in peaceful nuclear energy and pharmaceuticals after high-level negotiations. The partnership targets civilian nuclear technology, energy infrastructure, and joint drug production to strengthen local industrial capacity. This move aligns with BRICS’ push for technological sovereignty and long-term resilience.
Brazil and Russia agreed to expand cooperation in peaceful nuclear energy and pharmaceuticals following high-level talks in Brasília. The discussions focused on civilian nuclear technology, energy generation infrastructure, and joint pharmaceutical production and research.
Both sides emphasized technology transfer and local capacity building to strengthen industrial independence. Nuclear cooperation is strictly non-military, while pharmaceutical projects aim to increase domestic drug manufacturing and scientific exchange.
The agreement reflects deeper coordination inside the BRICS framework, where members are prioritizing strategic technologies, healthcare resilience, and reduced reliance on external suppliers.